
Did you lose money investing with Stephen Hurtuk (CRD# 848484)?
Galvin Legal, PLLC is launching an investigation on behalf of investors who may have suffered losses investing with Stephen Hurtuk. If you suffered losses investing with Stephen Hurtuk, then Galvin Legal, PLLC may be able to help you recover your losses in a Financial Industry Regulatory Authority (“FINRA“) arbitration claim.
If you suffered losses and would like a free consultation with a securities attorney, then please call Galvin Legal, PLLC at 1-800-405-5117.
As of October 22, 2020, Stephen Hurtuk’s FINRA BrokerCheck Report contains the following:
BARRED: FINRA has barred this individual from acting as a broker or otherwise associating with a broker-dealer firm.
Disclosure Events
7 Customer Dispute(s)
1 Regulatory Event(s)
See FINRA Letter of Acceptance, Waiver and Consent No. 2016051215301
UPDATE 10/22/2020: According to FINRA’s November 2018 Disciplinary Actions: “Stephen Thomas Hurtuk (CRD #848484, Boardman, Ohio) September 5, 2018 – An AWC was issued in which Hurtuk was barred from association with any FINRA member in all capacities. Without admitting or denying the findings, Hurtuk consented to the sanction and to the entry of findings that he refused to appear for FINRA on-the-record testimony in connection with its investigation into potentially unsuitable recommendations by Hurtuk to customers. (FINRA Case #2016051215301)”
Current and Previous Registrations
10/26/2007 – 10/24/2017 STIFEL, NICOLAUS & COMPANY, INCORPORATED (CRD#:793) BOARDMAN, OH
04/30/2001 – 10/22/2007 CITIGROUP GLOBAL MARKETS INC. (CRD#:7059) CANFIELD, OH
09/26/1978 – 05/02/2001 MERRILL LYNCH, PIERCE, FENNER & SMITH INCORPORATED (CRD#:7691) NEW YORK, NY
02/01/1978 – 09/26/1978 MERRILL LYNCH, PIERCE, FENNER & SMITH, INC. (CRD#:572)
If you suffered losses and would like a free consultation with a securities attorney, then please call Galvin Legal, PLLC at 1-800-405-5117.
Due Diligence Requirement
FINRA requires broker’s to conduct due diligence on investments and to conduct a suitability analysis when recommending securities to a customer that takes into account the customer’s knowledge and experience. FINRA Rule 2111(a) states that “a member or an associated person must have a reasonable basis to believe that a recommended transaction or investment strategy involving a security or securities is suitable for the customer, based on the information obtained through the reasonable diligence of the member or associated person to ascertain the customer’s investment profile. A customer’s investment profile includes, but is not limited to, the customer’s age, other investments, financial situation and needs, tax status, investment objectives, investment experience, investment time horizon, liquidity needs, risk tolerance, and any other information the customer may disclose to the member or associated person in connection with such recommendation.”
Rule 2111 is composed of three main obligations: reasonable-basis suitability, customer-specific suitability, and quantitative suitability. Brokers and the brokerage firms they work for that fail to conduct adequate due diligence on investments they recommend or that make unsuitable recommendations can be held responsible for the customer’s losses in a FINRA arbitration claim.
If you suffered losses and would like a free consultation with a securities attorney, then please call Galvin Legal, PLLC at 1-800-405-5117.
Request a Free Consultation with a Securities Attorney
If you suffered losses investing with Stephen Hurtuk and would like a free consultation with a securities attorney, then please call Galvin Legal, PLLC at 1-800-405-5117.
This information is all publicly available and is being provided to you by Galvin Legal, PLLC.
Galvin Legal, PLLC is a national securities arbitration, securities mediation, securities litigation, securities fraud, securities regulation and compliance, and investor protection law practice. For more information on Galvin Legal, PLLC and its representation of investors, please visit www.galvinlegal.com or call 1-800-405-5117.
